Montelukast Sodium Patent Expiration
Montelukast Sodium is Used for treating Asthma It was first introduced by Organon Llc A Sub Of Organon And Co
Montelukast Sodium Patents
Given below is the list of patents protecting Montelukast Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Singulair | US8007830 | Granule formation |
Oct 24, 2022
(Expired) | Organon |
| Singulair |
US5565473 (Pediatric) | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
Aug 03, 2012
(Expired) | Organon |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Montelukast Sodium's patents.
Latest Legal Activities on Montelukast Sodium's Patents
Given below is the list recent legal activities going on the following patents of Montelukast Sodium.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent Critical
| 02 Oct, 2023 | US8007830 |
| Maintenance Fee Reminder Mailed Critical
| 19 Apr, 2023 | US8007830 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 16 Jan, 2019 | US8007830 |
| Recordation of Patent Grant Mailed Critical
| 30 Aug, 2011 | US8007830 |
| Patent Issue Date Used in PTA Calculation Critical
| 30 Aug, 2011 | US8007830 |
| Issue Notification Mailed Critical
| 10 Aug, 2011 | US8007830 |
| Application Is Considered Ready for Issue Critical
| 26 Jul, 2011 | US8007830 |
| Dispatch to FDC | 26 Jul, 2011 | US8007830 |
| Issue Fee Payment Received Critical
| 25 Jul, 2011 | US8007830 |
| Issue Fee Payment Verified Critical
| 25 Jul, 2011 | US8007830 |
Montelukast Sodium's Family Patents
